Skip to main content
logo
Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0022
-0.0023 (-51.11%)
At close: Jul 29, 2026

Carisma Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
017118---
Market Cap Growth
-99.40%-85.21%----
Enterprise Value
-2-727---
Last Close Price
0.000.422.93---

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.000.897.93---
PB Ratio
-0.11-0.634.46---
P/TBV Ratio
--4.46---

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
--1.80---

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-0.88-0.090.12-1.150.100.07
Net Debt / Equity Ratio
2.320.59-2.840.34-1.00-0.96
Net Debt / EBITDA Ratio
-0.140.290.880.220.651.73
Net Debt / FCF Ratio
0.090.270.921.210.661.76
Asset Turnover
2.170.330.190.18--
Quick Ratio
0.651.354.932.643.719.12
Current Ratio
0.861.485.062.783.879.34
Return on Equity (ROE)
-----107.08%-
Return on Assets (ROA)
33.03%-62.68%-68.59%-65.24%-54.30%-
Return on Capital Employed (ROCE)
-4979.50%-417.80%-120.50%-107.00%-147.00%-53.80%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
8735.70%-345.88%-73.47%---
FCF Yield
-24348.52%-343.38%-69.61%---
Buyback Yield / Dilution
-1.84%-23.66%-1475.33%-96.30%-1.95%-